Thyroid Cancer Incidence Among Korean Individuals: A Comparison of South Korea and the United States
The Laryngoscope · 2024
DOI: 10.1002/lary.31490 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Laryngoscope, 2024. Verfasst von Dohun Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Busan Paik Hospital, Inje University, Busan, Korea. Hauptthemen laut MEDLINE: SEER Program, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Busan Paik Hospital, Inje University.
Abstract (Originalsprache)
Objective
To compare thyroid cancer incidence rates and trends between Korean, non‐Korean Asian, and non‐Hispanic White populations in the United States, and between the US Korean population and the South Korean population.
Method
Population‐based analysis of cancer incidence data. Cases of thyroid cancer diagnosed during 1999–2014 from the Korean Central Cancer Registry (KCCR) and the Surveillance, Epidemiology, and End Results (SEER) 9 detailed Asian/Pacific Islander subgroup incidence and population dataset were included. Incidence rates were obtained from the datasets, and annual percent change (APC) of the incidence rates was calculated using Joinpoint regression analysis.
Results
Thyroid cancer incidence rate for 1999–2014 was significantly higher for South Korea (48.05 [95% CI 47.89–48.22] per 100,000 person‐years) than for the US Korean population (11.12 [95% CI 10.49–11.78] per 100,000 person‐years), which was slightly higher than the Non‐Korean Asian population (10.23 [95% CI 10.02–10.43] per 100,000 person‐years), and slightly lower than the Non‐Hispanic White population (12.78 [95% CI 12.69–12.87] per 100,000 person‐years). Incidence rates in South Korea increased dramatically (average APC 17.9, 95% CI 16.0–19.9), significantly higher than the US Korean population (average APC 5.0, 95% CI 3.1–6.8), which was similar to the non‐Korean Asian (average APC 2.5, 95% CI 0.9–4.2) and the non‐Hispanic White (average APC 5.1, 95% CI 4.7–5.6) populations.
Conclusions
South Korea's high thyroid cancer incidence rates cannot be attributed to genetic factors, but are likely due to health care system factors. Level of Evidence 3 Laryngoscope , 134:4156–4160, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Busan Paik Hospital, Inje University, Busan, Korea.
- Department of Otolaryngology and Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, U.S.A.
- Department of Pharmacology, College of Medicine, Busan Paik Hospital, Inje University, Busan, Korea.
ORCID-Profile: Peter K Moon, Uchechukwu C Megwalu
Förderung
- Busan Paik Hospital, Inje University
Zitieren
APA
Kim, D., Li, G., Moon, P. K., Ma, Y., Sim, S., Park, S. Y., Oh, M., & Megwalu, U. C. (2024). Thyroid Cancer Incidence Among Korean Individuals: A Comparison of South Korea and the United States. The Laryngoscope. https://doi.org/10.1002/lary.31490
Vancouver
Kim D, Li G, Moon PK, Ma Y, Sim S, Park SY, et al. Thyroid Cancer Incidence Among Korean Individuals: A Comparison of South Korea and the United States. The Laryngoscope. 2024. doi:10.1002/lary.31490
BibTeX
@article{Kim2024,
author = {Kim, Dohun and Li, Guan and Moon, Peter K and Ma, Yifei and Sim, Soohyun and Park, Sung Y and Oh, Minkyung and Megwalu, Uchechukwu C},
title = {Thyroid Cancer Incidence Among Korean Individuals: A Comparison of South Korea and the United States},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31490}
}
EUVIMED